Versigent (NYSE:VGNT) Announces Earnings Results

Versigent (NYSE:VGNT) posted its earnings results on Tuesday. The company reported $1.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.58 by $0.34, Zacks reports.

Here are the key takeaways from Versigent’s conference call:

• Versigent reported strong second-quarter results, with net sales up 11% year over year to $2.4 billion, adjusted EBITDA up 25% to $272 million, and margin expanding 120 basis points to 11.1%. Underlying adjusted sales growth was approximately 5%, outpacing relatively flat-to-down global automotive production.
• The company cited robust commercial momentum, including $2.8 billion in second-quarter bookings and 39 large-scale program launches with more than 99% quality and on-time delivery. Growth was particularly strong in the Americas and Asia-Pacific, supported by customer launches and China-related vehicle exports.
• Versigent raised its 2026 sales guidance to $9.4 billion-$9.6 billion, primarily due to higher copper pass-throughs and favorable foreign exchange, but maintained adjusted EBITDA guidance of $950 million-$1.03 billion because those macro benefits are not expected to materially improve profitability. The company also reaffirmed free cash flow guidance of $200 million-$300 million.
• Management expects second-half pressure from lower global automotive production, customer-specific schedule reductions, softer EMEA demand, and temporary volume and absorption impacts from an unusually high number of program launches. European adjusted sales declined 11% in the quarter, prompting targeted actions to improve regional competitiveness.
• The company initiated a quarterly dividend of $0.13 per share and has $250 million remaining under its share-repurchase authorization, supported by its projected cash generation and approximately $1 billion of cumulative free cash flow from 2026 through 2028. Management also identified commercial vehicles, agriculture, battery energy storage, and robotics as potential longer-term growth opportunities not included meaningfully in its 2028 outlook.

Versigent Trading Up 8.3%

Shares of NYSE VGNT traded up $3.50 during midday trading on Tuesday, hitting $45.54. 650,747 shares of the company’s stock were exchanged, compared to its average volume of 2,068,853. The firm has a fifty day moving average price of $43.28. Versigent has a 12-month low of $26.34 and a 12-month high of $50.88.

Analyst Ratings Changes

Several brokerages have commented on VGNT. Argus set a $50.00 target price on Versigent in a research note on Tuesday, July 21st. Oppenheimer set a $50.00 price target on Versigent in a research report on Tuesday, July 21st. Evercore reissued an “outperform” rating and issued a $60.00 price target on shares of Versigent in a report on Monday, May 18th. Royal Bank Of Canada raised their price objective on shares of Versigent from $34.00 to $41.00 and gave the company a “sector perform” rating in a research report on Monday, July 13th. Finally, Wall Street Zen raised shares of Versigent to a “hold” rating in a research note on Saturday, April 18th. Three investment analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $49.67.